Marina Talamonti
41PUBLICATIONS
89CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (41)
Sort by Publication Date:
|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.Emanuele Trovato, Claudio Bonifati, Simone Ribero
|Jan 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis.Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli
|Nov 03, 2025
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.Niccolò Gori, Lucia Di Nardo, Elena Ippoliti
|Sep 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study.Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli
|Jun 27, 2025
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study.Edoardo Mortato, Marina Talamonti, Claudia Paganini
|Jun 09, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?Edoardo Mortato, Niccolò Gori, Giacomo Caldarola
Pageof 7
Frequent Collaborators
37 joint publications
Marco Galluzzo
15 joint publications
Luca Bianchi
5 joint publications
Edoardo Mortato
5 joint publications
Cosimo Di Raimondo
5 joint publications
Andrea Chiricozzi
5 joint publications
Lorenzo Tofani
4 joint publications
Claudia Paganini
4 joint publications
Nicoletta Bernardini
3 joint publications
Laura Atzori
3 joint publications
Elena Campione
